60
Typewriter Therapeutics, Inc. raises $56.3M under Reg D
Company raise · Closed · CAMBRIDGE, MA · Form D filed 2026-09-21
$50M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Laura Tadvalkar | Director |
| Matthew Stanton | Executive Officer, Director |
| Kenneth Horne | Director |
| Mikael Dolston | Director |
Signed by Matthew Stanton, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.